Tech

87-Year-Old Biohacker Spends £500k on Quest to ‘Live Forever’

87-Year-Old Biohacker Spends £500k on Quest to ‘Live Forever’ - News Directory 3

At 87, Helga Sands could be forgiven for embracing a quiet retirement. Instead, she’s embarked on a quest to significantly extend her lifespan, pursuing a regimen of experimental therapies and supplements that push the boundaries of longevity science. Her approach, while unconventional, highlights a growing trend: the proactive pursuit of extended healthspan, not just lifespan, even among older generations.

Next month, Sands plans to travel to Panama for a “rejuvenation cocktail” costing £300,000, a treatment unavailable in the UK. She currently manages an estimated 70 supplements daily, employs unusual personal care practices like washing her hair with sheep shampoo and sleeping on silver-threaded sheets (intended to reduce inflammation) and undergoes regular injections of microscopic molecules derived from amniotic fluid. Over the past five years, she estimates spending £500,000 on these anti-aging therapies.

“You might like the idea of dying and going to heaven but I have no interest,” Sands stated, “I want to keep living because I still have so much to live for. I’m not slowing down but speeding up. Here’s a new life.”

The pursuit of longevity is often associated with younger, affluent entrepreneurs like Bryan Johnson, 48, who has gained notoriety for his extreme biohacking, including, previously, blood transfusions from his son. Mark Zuckerberg, 41, has also invested heavily in anti-aging research. Sands, however, represents a different demographic – a seasoned individual drawing on a lifetime of experience and financial independence to explore the possibilities of extending her healthy years.

Born in 1938, Sands’ life has been marked by significant historical events. She fled Nazi Germany as a child and later endured a challenging journey back to her homeland, walking for eight months from Czechoslovakia to Düsseldorf while evading gunfire. She later moved to the United States and then Paris, eventually settling in London in the mid-1980s, where she worked in the City for major American banks, becoming one of the first female directors in fixed income at Nomura.

Sands’ foray into longevity research began after her retirement in 1997. She has since attended conferences globally, connecting with researchers and accessing treatments not readily available due to regulatory restrictions. She claims these therapies are yielding positive results, including increased muscle mass, improved balance, and the resolution of lingering health issues. However, her friends find it difficult to keep pace with her active lifestyle.

Her daily routine, while supplemented by experimental treatments, isn’t entirely radical. She walks regularly with her partner, avoids processed foods, limits gluten intake, and enjoys white wine in moderation. It’s the additional therapies that set her regimen apart.

These therapies include dasatinib and quercetin, compounds she combines into a powder added to her shampoo and smoothies, costing “just a few hundred dollars.” She also undergoes regular blood filtration, ozone infusion, and injections of exosomes – stem cell-derived molecules sourced from amniotic fluid, administered every three months at a cost of £2,000 per treatment.

The most ambitious undertaking is the “rejuvenation cocktail” she’s developing in collaboration with a Houston-based American lab. This cocktail comprises three key components: klotho (a protein aimed at enhancing brain function), follistatin (for building muscle mass), and SIRT1 (an enzyme intended to boost energy levels). Sands and her partner have invested approximately £300,000 in this project, with the goal of eventually producing and selling the therapy through a newly founded rejuvenation start-up.

Many of these treatments are not approved by British regulators, requiring Sands to purchase products online from countries with less stringent regulations and self-administer them. Experts caution against this approach. Ilaria Bellantuono, a professor of musculoskeletal ageing at the University of Sheffield, emphasized that the safety and effectiveness of these therapies haven’t been established through rigorous clinical trials and should be avoided.

Sands remains undeterred, stating she is “absolutely” prepared to accept the risks. She views her efforts not only as a personal pursuit of longevity but also as a pioneering endeavor that could benefit others in the future. “There are therapies out there that work but people don’t have a clue about,” she said. “And then there are the regulations that get in the way. So we say: the hell with it. We’re going to do it.”

Bryan Johnson, a prominent figure in the biohacking space, currently spends around $2 million annually on his de-aging efforts, as reported in by UNILAD. He previously explored blood transfusions from his son but has since moved to total plasma exchange, a more extreme procedure involving removing and replacing his blood plasma. Johnson, , stated his goal is to achieve a biological age of 18, according to a TikTok video.